남성용 미용 시장 : 시술 유형, 기술, 제공자 유형, 시술 빈도, 효과 지속 기간별 - 세계 예측(2026-2032년)

The Male Aesthetics Market is projected to grow by USD 10.65 billion at a CAGR of 7.65% by 2032.

Male aesthetics has moved from a niche category into a measurable segment of the global aesthetic medicine industry, supported by demand for minimally invasive cosmetic procedures, dermatology-led skin health, body contouring, hair restoration, and discreet facial rejuvenation. Verified procedure datasets from professional societies, including ISAPS, ASPS, and AAFPRS, consistently show that men account for a meaningful share of cosmetic procedure demand, with botulinum toxin, dermal fillers, laser-based treatments, hair procedures, rhinoplasty, eyelid surgery, and gynecomastia-related services among recurring areas of interest.

For manufacturers, distributors, aesthetic technology suppliers, and service providers, momentum is being shaped by gender-specific treatment planning, workplace and social-media visibility, rising acceptance of self-care among men, and improved access through dermatology practices, plastic surgery clinics, medical spas, hair restoration centers, and digital consultation channels. The sector is increasingly defined by subtle results, shorter recovery times, medical-grade skincare, and procedures that support a refreshed yet masculine appearance.

Transformative Shifts in the Male Aesthetics Landscape

The male aesthetics landscape is being reshaped by three structural shifts: normalization of cosmetic care among men, preference for low-downtime procedures, and the convergence of dermatology, wellness, grooming, and regenerative aesthetics. Men increasingly seek natural-looking outcomes that preserve masculine facial structure, including jawline definition, chin projection, skin texture improvement, hair density support, acne scar revision, and body composition enhancement.

Commercially, the market is shifting from episodic procedure sales toward lifetime patient management. Providers are bundling neuromodulators, fillers, energy-based devices, prescription skincare, hair therapies, and maintenance visits into structured care plans, while brands are adapting language, packaging, education, and digital advertising to address male-specific motivations such as confidence, professional appearance, fitness alignment, age management, and discreet self-improvement.

Cumulative Impact of Artificial Intelligence in Male Aesthetics

Artificial intelligence is becoming an enabling layer across male aesthetics rather than a standalone replacement for clinical judgment. AI-supported imaging, facial analysis, skin assessment, hair-density evaluation, patient journey automation, and treatment simulation are helping clinics personalize consultations, improve patient education, and support documentation and follow-up. In aesthetic medicine, these applications are particularly relevant where objective baseline assessment and visual outcome planning influence patient confidence.

The cumulative impact is strongest where AI is used with verified clinical protocols, consent-based data capture, and qualified medical oversight. For industry participants, AI can support device utilization, lead scoring, inventory planning, appointment conversion, patient retention, and post-treatment monitoring; however, compliance with privacy laws, bias testing, cybersecurity safeguards, and transparent claims management remain essential to protect patient trust and regulatory standing.

Key Regional Insights: Male Aesthetics Demand by Geography

Asia-Pacific is one of the most dynamic regions for male aesthetics, supported by South Korea's advanced cosmetic procedure ecosystem, Japan's mature dermatology market, China's expanding urban clinic networks, India's rapid growth in hair restoration and dermatology services, and Australia's regulated cosmetic practice environment. North America remains highly developed, with the United States and Canada benefiting from strong provider density, established injectable adoption, direct-to-consumer education, digital booking behavior, and medical spa expansion.

Latin America is anchored by Brazil and Mexico, where plastic surgery expertise, medical tourism, and price accessibility support demand for cosmetic procedures and hair-related treatments. Europe is shaped by strict medical-device, consumer protection, and data-protection frameworks, favoring evidence-based suppliers and medically supervised practice models. The Middle East, led by GCC markets, is expanding through premium clinics, medical tourism, and high discretionary spending in urban centers, while Africa remains emerging, with growth concentrated in South Africa, Nigeria, Kenya, Egypt, and private healthcare networks serving urban male consumers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN growth is supported by Thailand, Singapore, Malaysia, Indonesia, Vietnam, and the Philippines, where medical tourism, dermatology clinics, private healthcare investment, and rising middle-income populations are expanding access to injectables, lasers, skincare procedures, and hair treatments. GCC markets, including Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman, favor premium aesthetic centers, advanced devices, specialist physicians, and culturally adapted consultation models that emphasize privacy, trust, and natural-looking outcomes.

The European Union emphasizes compliance with medical-device regulation, data privacy, clinical documentation, and medical advertising rules, creating advantages for clinically validated technologies and professionalized service delivery. BRICS countries combine large populations with expanding private healthcare demand, although pricing, reimbursement, import pathways, and professional regulation vary widely across member economies. G7 markets remain innovation-led, with higher adoption of injectables, energy-based platforms, dermatology-led skincare, and AI-enabled workflows. NATO countries overlap with many high-income healthcare systems, supporting resilient supply chains, standardized quality expectations, and stronger demand for regulated aesthetic technologies.

Key Country Insights: Priority Markets for Male Aesthetics

The United States leads in procedure availability, injectable innovation, medical spa penetration, plastic surgery access, and digital patient acquisition, while Canada shows steady demand within a regulated medical and advertising environment. Mexico and Brazil benefit from medical tourism, strong plastic surgery cultures, and established cosmetic surgery expertise. The United Kingdom, Germany, France, Italy, and Spain are characterized by mature aesthetic medicine adoption, stricter advertising expectations, and demand for natural results, while Russia maintains a sizeable urban aesthetics market despite geopolitical, payment, and supply-chain constraints.

China offers scale through urban clinics, digital platforms, and rising male grooming acceptance, while India shows high momentum in hair restoration, dermatology, acne scar treatment, and skin health services. Japan prioritizes quality, safety, and subtle outcomes, supported by a mature medical consumer base. Australia benefits from professional regulation and an active cosmetic clinic ecosystem, and South Korea remains a global reference point for aesthetic innovation, male grooming culture, facial contouring, skincare, and minimally invasive procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should build male-specific clinical pathways rather than repackaging female-oriented messaging. High-performing strategies include treatment protocols for jawline definition, chin balance, skin quality, hair restoration, body contouring, acne scarring, under-eye rejuvenation, and age management, supported by education that emphasizes natural, professional, and discreet outcomes.

Companies should invest in compliant AI tools, physician training, evidence generation, standardized photography, patient consent workflows, and omnichannel engagement. Regional pricing, culturally relevant campaigns, robust adverse-event monitoring, and partnerships with dermatologists, plastic surgeons, hair specialists, fitness communities, grooming platforms, and wellness providers can improve acquisition, retention, and long-term brand credibility.

Research Methodology

This executive summary is based on secondary research and triangulation from professional society publications, regulatory databases, peer-reviewed dermatology and plastic surgery literature, government healthcare sources, clinical guidance, trade indicators, and publicly available industry documentation. Key reference points include organizations and authorities such as ISAPS, ASPS, AAFPRS, FDA, EMA, national statistics agencies, and official public health and regulatory resources.

The analysis applies segmentation by procedure type, end user, region, and adoption driver, supported by PESTLE assessment, regulatory review, competitive benchmarking, and demand-side interpretation. Findings are framed conservatively to avoid unsupported claims, market estimation, market sizing, market share references, or forecasting, and to reflect verifiable trends in male aesthetic medicine.

Conclusion: Strategic Outlook for Male Aesthetics

Male aesthetics is entering a more sophisticated growth phase defined by personalization, medical credibility, digital access, subtle outcomes, and AI-supported patient engagement. Demand is broadening from corrective procedures to preventive, confidence-oriented, and maintenance-based aesthetic care across injectables, dermatology services, energy-based devices, hair restoration, body contouring, and medical-grade skincare.

The strongest opportunities will belong to organizations that combine clinical evidence, male-specific positioning, ethical AI, regulatory discipline, safety monitoring, and localized go-to-market execution. As social acceptance rises and treatment options become more precise, male aesthetics is positioned to remain a durable and strategically important category within global aesthetic medicine.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Male Aesthetics Market, by Treatment Type

• 7.1. Minimally Invasive Procedures
  • 7.1.1. Fat Transfer
  • 7.1.2. Laser-Assisted Lipolysis
  • 7.1.3. Liposuction
  • 7.1.4. Thread Lifts
• 7.2. Non-Invasive Procedures
  • 7.2.1. Body Contouring
  • 7.2.2. Botox Injectables
  • 7.2.3. Hair Removal
  • 7.2.4. Hair Restoration (Non-Surgical)
  • 7.2.5. Pigment/Scar Correction
  • 7.2.6. Skin Resurfacing
  • 7.2.7. Skin Tightening
• 7.3. Surgical Procedures
  • 7.3.1. Body Surgery
  • 7.3.2. Facial Surgery
  • 7.3.3. Hair Transplant
• 7.4. Topicals & At-Home
  • 7.4.1. At-Home Devices
  • 7.4.2. Skincare

8. Male Aesthetics Market, by Technology

• 8.1. Laser Technology
• 8.2. Radiofrequency
• 8.3. Ultrasound

9. Male Aesthetics Market, by Provider Type

• 9.1. Barbershop-Adjacent Grooming Clinics
• 9.2. Dermatology Clinics
• 9.3. Franchised Chains
• 9.4. Medical Spas

10. Male Aesthetics Market, by Treatment Frequency

• 10.1. Maintenance/Booster
• 10.2. One-Time
• 10.3. Series-Based

11. Male Aesthetics Market, by Outcome Duration

• 11.1. Long-Lasting (>24 Months)
• 11.2. Permanent
• 11.3. Semi-Permanent (6-24 Months)
• 11.4. Temporary (<=6 Months)

12. Male Aesthetics Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Male Aesthetics Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Male Aesthetics Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. 3M Company
• 16.2. Abbvie Inc.
• 16.3. Acumed, LLC by Colson Medical, LLC
• 16.4. Alma Lasers, Ltd.
• 16.5. Anthony Skin LLC
• 16.6. Candela Corporation
• 16.7. Cartessa Aesthetics
• 16.8. Cutera, Inc.
• 16.9. Cynosure, LLC
• 16.10. Galderma SA
• 16.11. Hanson Medical, Inc.
• 16.12. Implantech Associates Inc.
• 16.13. Inmode Ltd
• 16.14. Institut Straumann AG
• 16.15. Integra LifeSciences Corporation
• 16.16. Ipsen Pharma
• 16.17. Jeisys Medical Inc.
• 16.18. Johnson & Johnson Services Inc.
• 16.19. KLS Martin Group
• 16.20. Lattice Medical SAS
• 16.21. Medytox, Inc.
• 16.22. Merz Aesthetics, Inc.
• 16.23. Nobel Biocare Services AG
• 16.24. Quanta System S.p.A.
• 16.25. Solta Medical by Bausch Health Companies Inc.
• 16.26. Stryker Corporation
• 16.27. Zimmer Biomet Holdings, Inc.